NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球醫藥原料 (API) 市場:行業趨勢、市場份額/規模/增長率/機遇和預測(2021-2026)

Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版商 IMARC Services Private Limited 商品編碼 1006990
出版日期 內容資訊 英文 108 Pages
商品交期: 2-3個工作天內
價格
全球醫藥原料 (API) 市場:行業趨勢、市場份額/規模/增長率/機遇和預測(2021-2026) Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
出版日期: 2021年05月20日內容資訊: 英文 108 Pages
簡介

2020 年全球活性藥物成分 (API) 市場價值達到 2006 億美元。藥物活性成分 (API) 是指藥物(片劑、膠囊等)的生物活性成分的術語。藥物通常由多種成分組成。 API代表主要成分。其他成分通常稱為 "賦形劑" 。有時,一種藥物可能含有多種 API,其對患者的影響取決於處方劑量和個體差異。在聯合治療中,使用兩種或多種活性成分進行治療。嚴格的質量控制對於藥品的製造是強制性的,因為 API 是創建處方時要考慮的關鍵組成部分。

藥品生產分為兩個常見步驟。第一步,製造商將原材料轉換為 API。第二步是將原料藥和賦形劑混合成片劑、膠囊、溶液等,製成最終配方,最後為最終用戶包裝藥物。製造商要麼在公開市場(也稱為商業市場)上銷售 API,要麼使用 API 作為原材料來創建最終配方。全球API市場在眾多大大小小的製造商之間競爭激烈。從事 API 製造的公司通常專注於製造,並根據公司內部的技能和市場機會設定目標。在成本降低的支持下,原料藥製造正逐漸從主要的西方製造商轉向印度和中國的製造商。

全球對 API 的需求目前呈現強勁增長。該市場的主要驅動力之一是重磅專利的到期日越來越長,這為通用 API 創造了重大機遇。生物製劑對 API 的需求也在不斷增長。由於其高效能和治療小分子藥物範圍以外的疾病的能力,全球生物製藥市場目前呈現強勁增長。這使得品牌生物製藥及其生物仿製藥對 API 產生了強烈需求。推動全球對 API 需求的其他因素包括人口老齡化、醫療保健支出增加以及與生活方式相關的疾病的流行。展望未來,預計全球 API 市場將在 2021-2026 年的預測期內溫和增長。

本報告調查全球醫藥活性成分 (API) 市場、行業趨勢、市場預測、藥物類型/合成類型/製造商類型/治療用途/區域市場分析、競爭形勢、公司簡介等信息。

市場細分:

目錄

第 1 章前言

第 2 章範圍和調查方法

第 3 章執行摘要

第 4 章介紹

第 5 章全球藥物活性成分 (API) 市場

  • 市場概覽
  • 市場表現
  • COVID-19 的影響
  • 按藥物類型劃分的市場細分
  • 按綜合類型細分市場
  • 按製造商類型劃分的市場細分
  • 按治療應用細分市場
  • 區域市場細分
  • SWOT 分析
    • 概述
    • 優勢
    • 弱點
    • 市場機會
    • 威脅
  • 價值鏈分析
  • 波特五力分析
  • 價格分析
    • 價格指數
    • 價格結構

第 6 章按藥物類型劃分的市場細分

  • 創新藥物活性成分 (API)
  • 仿製藥活性成分 (API)

第 7 章按製造商類型劃分的市場細分

  • 獨家製造商
  • 商家 API 製作工具
    • 創新的商家 API Maker
    • 通用商戶 API Maker

第 8 章按綜合類型劃分的市場細分

  • 合成活性成分 (API)
  • 生物技術藥物 (API) 的活性成分
    • 按產品細分市場
    • 按表達系統細分市場

第 9 章按治療應用進行的市場細分

  • 腫瘤學
  • 心血管和呼吸系統
  • 糖尿病
  • 中樞神經系統疾病
  • 神經系統疾病
  • 其他

第 10 章區域市場細分

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 拉丁美洲
  • 中東/弗裡卡

第 11 章原料藥生產工藝

  • 產品概覽
  • 原材料要求
  • 製造過程
  • 主要成功和風險因素

第 12 章競爭形勢

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Pfizer, Inc.
    • Novartis International AG
    • Sanofi
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • Teva Pharmaceutical Industries Ltd.
    • ELI Lilly and Company
    • GlaxoSmithKline
    • Merck & Co., Inc.
    • Abbvie Inc
目錄
Product Code: SR1020C70_Report

The global active pharmaceutical ingredients (API) market reached a value of US$ 200.6 Billion in 2020. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as "excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.

Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.

The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, IMARC Group expects the global active pharmaceutical ingredients (API) market to exhibit moderate growth during the forecast period (2021-2026).

Market Segmentation:

Breakup by Drug Type:

  • Innovative Active Pharmaceutical Ingredients (API)
  • Generic Active Pharmaceutical Ingredients (API)
  • Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.

Breakup by Manufacturer:

  • Captive Manufacturers
  • Merchant API Manufacturers
  • Innovative Merchant API Manufacturers
  • Generic Merchant API Manufacturers
  • Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
  • Breakup by Synthesis
  • Synthetic Active Pharmaceutical Ingredients (API)
  • Market Breakup by Type
  • Innovative Synthetic APIs
  • Generic Synthetic APIs
  • Biotech Active Pharmaceutical Ingredients (API)
  • Market Breakup by Type
  • Innovative Biotech APIs
  • Biosimilars
  • Market Breakup By Product
  • Monoclonal Antibodies
  • Vaccines
  • Cytokines
  • Fusion Proteins
  • Therapeutic Enzymes
  • Blood Factors
  • Market Breakup By Expression System
  • Mammalian Expression Systems
  • Microbial Expression Systems
  • Yeast Expression Systems
  • Transgenic Animal Systems
  • Others
  • Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.

Breakup by Therapeutic Application:

  • Oncology
  • Cardiovascular and Respiratory
  • Diabetes
  • Central Nervous System Disorders
  • Neurological Disorders
  • Others
  • Based on the therapeutic application, the market has been segmented as oncology, cardiovascular & respiratory, diabetes, central nervous system disorders, neurological disorders and others.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Middle East and Africa
  • Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Competitive Landscape:

  • The competitive landscape of the market has also been examined with some of the (active pharmaceutical ingredients companies) key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.

Key Questions Answered in This Report:

  • How has the global active pharmaceutical ingredients (API) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global active pharmaceutical ingredients (API) industry?
  • What are the key regional markets in the global active pharmaceutical ingredients (API) industry?
  • What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of drug type?
  • What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of type of manufacturer?
  • What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of synthesis?
  • What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of therapeutic application?
  • What are the various stages in the value chain of the global active pharmaceutical ingredients (API) market?
  • What are the key driving factors and challenges in the global active pharmaceutical ingredients (API) market?
  • What is the structure of the global active pharmaceutical ingredients (API) market and who are the key players?
  • What is the degree of competition in the global active pharmaceutical ingredients (API) market?
  • How are active pharmaceutical ingredients (API) manufactured?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Active Pharmaceutical Ingredients (API) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Drug Type
  • 5.5 Market Breakup by Type of Manufacturer
  • 5.6 Market Breakup by Type of Synthesis
  • 5.7 Market Breakup by Therapeutic Application
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes
  • 5.13 Price Analysis
    • 5.13.1 Price Indicators
    • 5.13.2 Price Structure

6 Market Breakup by Drug Type

  • 6.1 Innovative Active Pharmaceutical Ingredients (API)
  • 6.2 Generic Active Pharmaceutical Ingredients (API)

7 Market Breakup by Type of Manufacturer

  • 7.1 Captive Manufacturers
  • 7.2 Merchant API Manufacturers
    • 7.2.1 Innovative Merchant API Manufacturers
    • 7.2.2 Generic Merchant API Manufacturers

8 Market Breakup by Type of Synthesis

  • 8.1 Synthetic Active Pharmaceutical Ingredients (API)
    • 8.1.1 Market Breakup by Type
      • 8.1.1.1 Innovative Synthetic APIs
      • 8.1.1.2 Generic Synthetic APIs
  • 8.2 Biotech Active Pharmaceutical Ingredients (API)
    • 8.2.1 Market Breakup by Type
      • 8.2.1.1 Innovative Biotech APIs
      • 8.2.1.2 Biosimilars
    • 8.2.2 Market Breakup by Product
      • 8.2.2.1 Monoclonal Antibodies
      • 8.2.2.2 Vaccines
      • 8.2.2.3 Cytokines
      • 8.2.2.4 Fusion Proteins
      • 8.2.2.5 Therapeutic Enzymes
      • 8.2.2.6 Blood Factors
    • 8.2.3 Market Breakup by Expression System
      • 8.2.3.1 Mammalian Expression Systems
      • 8.2.3.2 Microbial Expression Systems
      • 8.2.3.3 Yeast Expression Systems
      • 8.2.3.4 Transgenic Animal Systems
      • 8.2.3.5 Others

9 Market Breakup by Therapeutic Application

  • 9.1 Oncology
  • 9.2 Cardiovascular and Respiratory
  • 9.3 Diabetes
  • 9.4 Central Nervous System Disorders
  • 9.5 Neurological Disorders
  • 9.6 Others

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 United Kingdom
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Russia
    • 10.2.7 Others
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Others
  • 10.4 Latin America
  • 10.5 Middle East and Africa

11 API Manufacturing Process

  • 11.1 Product Overview
  • 11.2 Raw Material Requirements
  • 11.3 Manufacturing Process
  • 11.4 Key Success and Risk Factors

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 Pfizer, Inc.
    • 12.3.2 Novartis International AG
    • 12.3.3 Sanofi
    • 12.3.4 Boehringer Ingelheim
    • 12.3.5 Bristol-Myers Squibb
    • 12.3.6 Teva Pharmaceutical Industries Ltd.
    • 12.3.7 ELI Lilly and Company
    • 12.3.8 GlaxoSmithKline
    • 12.3.9 Merck & Co., Inc.
    • 12.3.10 Abbvie Inc

List of Figures

  • Figure 1: Global: Active Pharmaceutical Ingredients (API) Market: Major Drivers and Challenges
  • Figure 2: Global: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Drug Type (in %), 2020
  • Figure 4: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Type of Manufacturer (in %), 2020
  • Figure 5: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Type of Synthesis (in %), 2020
  • Figure 6: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Therapeutic Application (in %), 2020
  • Figure 7: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Active Pharmaceutical Ingredients (API) Industry: SWOT Analysis
  • Figure 10: Global: Active Pharmaceutical Ingredients( API) Industry: Value Chain Analysis
  • Figure 11: Global: Active Pharmaceutical Ingredients (API) Industry: Porter's Five Forces Analysis
  • Figure 12: Active Pharmaceutical Ingredients (API) Manufacturing: Price Structure (in %)
  • Figure 13: Global: Innovative Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Innovative Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Generic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Generic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market: Sales Value (in Billion US$), 2015-2020
  • Figure 20: Global: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 21: Global: Merchant API Manufacturers Market: Breakup by Type (in %), 2020
  • Figure 22: Global: Merchant Generic API Manufacturers Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Merchant Generic API Manufacturers Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Merchant Innovative API Manufacturers Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Merchant Innovative API Manufacturers Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Synthetic Active Pharmaceutical Ingredients (API) Market: Breakup by Type (in %), 2020
  • Figure 29: Global: Innovative Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Innovative Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Generic Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Generic Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Biotech Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Breakup by Type (in %), 2020
  • Figure 36: Global: Innovative Biotech Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Innovative Biotech Active Pharmaceutical Ingredients (API) Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Breakup by Product Type (in %), 2020
  • Figure 41: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Global: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System (in %), 2020
  • Figure 54: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Global: Biotech Active Pharmaceutical Ingredients (Transgenic Animal Systems) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Global: Biotech Active Pharmaceutical Ingredients (Transgenic Animal Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Global: Biotech Active Pharmaceutical Ingredients (Others) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Global: Biotech Active Pharmaceutical Ingredients (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Global: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Global: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Global: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory Disease) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Global: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Global: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Global: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Global: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Global: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Global: Active Pharmaceutical Ingredients (Neurological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Global: Active Pharmaceutical Ingredients (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Global: Active Pharmaceutical Ingredients (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Global: Active Pharmaceutical Ingredients (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: North America: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: North America: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: United States: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: United States: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Canada: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Canada: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Europe: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 83: Europe: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 84: Germany: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 85: Germany: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 86: France: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 87: France: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 88: United Kingdom: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 89: United Kingdom: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 90: Italy: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 91: Italy: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 92: Spain: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 93: Spain: Active Pharmaceutical Ingredients Market (API) Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 94: Russia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 95: Russia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 96: Others: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 97: Others: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 98: Asia Pacific: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 99: Asia Pacific: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 100: China: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 101: China: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 102: Japan: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 103: Japan: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 104: India: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 105: India: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 106: South Korea: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 107: South Korea: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 108: Australia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 109: Australia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 110: Indonesia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 111: Indonesia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 112: Others: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 113: Others: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 114: Middle East and Africa: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 115: Middle East and Africa: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 116: Latin America: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 117: Latin America: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 118: API Manufacturing (Chemical Synthesis): Process Flow

List of Tables

  • Table 1: Global: Active Pharmaceutical Ingredients (API) Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
  • Table 3: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2021-2026
  • Table 4: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Type of Synthesis (in Million US$), 2021-2026
  • Table 5: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Therapeutic Application (in Million US$), 2021-2026
  • Table 6: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Active Pharmaceutical Ingredients (API): Raw Material Requirements
  • Table 8: Active Pharmaceutical Ingredients (API): Equipment Requirements
  • Table 9: Global: Active Pharmaceutical Ingredients (API) Market: Competitive Structure
  • Table 10: Global: Active Pharmaceutical Ingredients (API) Market: Key Players